Common and Unique Biological Pathways Associated with Smoking Initiation/Progression, Nicotine Dependence, and Smoking Cessation
暂无分享,去创建一个
Ming D. Li | Ming D Li | Ju Wang | Ju Wang
[1] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[2] Ming D. Li,et al. Gene-based analysis suggests association of the nicotinic acetylcholine receptor β1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence , 2006, Human Genetics.
[3] Megan E. Piper,et al. Associations between phenylthiocarbamide gene polymorphisms and cigarette smoking. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[4] G. Swan,et al. Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR , 2005, The Pharmacogenomics Journal.
[5] Nilanjan Chatterjee,et al. DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2006, Pharmacogenetics and genomics.
[6] M. Reuter,et al. Pleiotropic effect of the TPH A779C polymorphism on nicotine dependence and personality , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[7] Mohamed Abdel Hamid,et al. DRD2/ANKK1 TaqI polymorphism and smoking behavior of Egyptian male cigarette smokers. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[8] W. Iacono,et al. Cholecystokinin (CCK) gene as a possible risk factor for smoking: a replication in two independent samples. , 2001, Molecular genetics and metabolism.
[9] Caryn Lerman,et al. Genetics and Drug Use as a Complex Phenotype , 2004, Substance use & misuse.
[10] M. Munafo,et al. Association of the mu-opioid receptor gene with smoking cessation , 2007, The Pharmacogenomics Journal.
[11] George C Patton,et al. Variation in the gene coding for the M5 Muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults , 2007, BMC Genetics.
[12] C. Ulrich,et al. Mismatch Repair Polymorphisms and Colorectal Polyps: hMLH1 −93G>A Variant Modifies Risk Associated with Smoking , 2006, The American Journal of Gastroenterology.
[13] S. S. St. Jeor,et al. D2 dopamine receptor gene and cigarette smoking: a reward gene? , 1994, Medical hypotheses.
[14] Xiang Yang Zhang,et al. Association of functional catechol O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers , 2007, Psychopharmacology.
[15] V. Hesselbrock,et al. Intronic variants in the dopa decarboxylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans. , 2006, Human molecular genetics.
[16] R. Tyndale,et al. Genetics of alcohol and tobacco use in humans , 2003, Annals of medicine.
[17] C. Lerman,et al. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial , 2004, The Pharmacogenomics Journal.
[18] Falk W. Lohoff,et al. Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking , 2007, Psychopharmacology.
[19] Virginia Health-System. Cigarette use among high school students--United States, 1991-2005. , 2006, MMWR. Morbidity and mortality weekly report.
[20] Michael C Neale,et al. Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[21] W. Maier,et al. Association of DNA Polymorphisms in the Synaptic Vesicular Amine Transporter Gene (SLC18A2) with Alcohol and Nicotine Dependence , 2005, Neuropsychopharmacology.
[22] Leena Peltonen,et al. Genome-wide association study of smoking initiation and current smoking. , 2009, American journal of human genetics.
[23] Mark J. Thomas,et al. Synaptic plasticity in the mesolimbic dopamine system. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[24] Caryn Lerman,et al. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. , 2008, Archives of general psychiatry.
[25] A. C. Collins,et al. The CHRNA5/A3/B4 Gene Cluster Variability as an Important Determinant of Early Alcohol and Tobacco Initiation in Young Adults , 2008, Biological Psychiatry.
[26] B. Wadzinski,et al. A Developmentally Regulated, Neuron-specific Splice Variant of the Variable Subunit Bβ Targets Protein Phosphatase 2A to Mitochondria and Modulates Apoptosis* , 2003, Journal of Biological Chemistry.
[27] Sally Murray. A smouldering epidemic , 2006, Canadian Medical Association Journal.
[28] Liping Wei,et al. Genes and (Common) Pathways Underlying Drug Addiction , 2007, PLoS Comput. Biol..
[29] K. Brady,et al. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. , 2006, Human molecular genetics.
[30] C. N. Lessov-Schlaggar,et al. Gender Differences in Determinants of Smoking Initiation and Persistence in California Twins , 2006, Cancer Epidemiology Biomarkers & Prevention.
[31] K. Kendler,et al. Association study of the Epac gene and tobacco smoking and nicotine dependence , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[32] J. Blendy,et al. Regulation of antidepressant activity by cAMP response element binding proteins , 2004, Molecular Neurobiology.
[33] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[34] C. Lerman,et al. Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers , 2005, Molecular Psychiatry.
[35] N. Martin,et al. Exploring the inter-relationship of smoking age-at-onset, cigarette consumption and smoking persistence: genes or environment? , 2007, Psychological Medicine.
[36] L. Epstein,et al. Catechol-O-Methyltransferase (COMT) Gene Variants Predict Response to Bupropion Therapy for Tobacco Dependence , 2007, Biological Psychiatry.
[37] Ming D. Li,et al. Significant Association of Catechol-O-Methyltransferase (COMT) Haplotypes with Nicotine Dependence in Male and Female Smokers of Two Ethnic Populations , 2006, Neuropsychopharmacology.
[38] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] Ming D. Li,et al. Association analysis of the protein phosphatase 1 regulatory subunit 1B (PPP1R1B) gene with nicotine dependence in European‐ and African‐American smokers , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[40] J R Hughes,et al. Antidepressants for smoking cessation. , 2014, The Cochrane database of systematic reviews.
[41] Ying Liu,et al. Association of habitual smoking and drinking with single nucleotide polymorphism (SNP) in 40 candidate genes: data from random population-based Japanese samples , 2005, Journal of Human Genetics.
[42] R. Tyndale,et al. CYP2E1*1D regulatory polymorphism: association with alcohol and nicotine dependence. , 2003, Pharmacogenetics.
[43] M C Neale,et al. A population-based twin study in women of smoking initiation and nicotine dependence , 1999, Psychological Medicine.
[44] T. Oyama,et al. Smoking cessation program and CYP2A6 polymorphism. , 2006, Frontiers in bioscience : a journal and virtual library.
[45] R. Walton,et al. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. , 2004, Pharmacogenetics.
[46] R. Malenka,et al. Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons , 2003, Neuron.
[47] Makiko Maeda,et al. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation , 2006, The Pharmacogenomics Journal.
[48] C. Jepson,et al. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine , 2006, Psychopharmacology.
[49] S S Smith,et al. The epidemiology of tobacco use, dependence, and cessation in the United States. , 1999, Primary care.
[50] N. Kato,et al. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior , 2007, Pharmacogenetics and genomics.
[51] J. Kauer. Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. , 2004, Annual review of physiology.
[52] K. Lynch,et al. Genetic correlations between smoking initiation and smoking behaviors in a twin sample. , 2006, Addictive behaviors.
[53] Ming D. Li,et al. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. , 2005, Human molecular genetics.
[54] P. Fletcher,et al. Serotonin receptors as potential targets for modulation of nicotine use and dependence. , 2008, Progress in brain research.
[55] H. Issaq,et al. Nicotine metabolism and CYP2D6 phenotype in smokers. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[56] L. Epstein,et al. Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials , 2006, Neuropsychopharmacology.
[57] Ming D. Li,et al. Fine mapping of a linkage region on chromosome 17p13 reveals that GABARAP and DLG4 are associated with vulnerability to nicotine dependence in European-Americans. , 2007, Human molecular genetics.
[58] C. Montag,et al. The Role of the TPH1 and TPH2 Genes for Nicotine Dependence: A Genetic Association Study in Two Different Age Cohorts , 2007, Neuropsychobiology.
[59] Ming D. Li,et al. DOPA decarboxylase gene is associated with nicotine dependence. , 2006, Pharmacogenomics.
[60] Pooja Mittal,et al. A novel signaling pathway impact analysis , 2009, Bioinform..
[61] Scott F. Saccone,et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. , 2007, Human molecular genetics.
[62] Gail P Jarvik,et al. Multiple genome-wide analyses of smoking behavior in the Framingham Heart Study , 2003, BMC Genetics.
[63] K. Kendler,et al. RhoA, encoding a Rho GTPase, is associated with smoking initiation , 2007, Genes, brain, and behavior.
[64] J. Hell,et al. The Spinocerebellar Ataxia 12 Gene Product and Protein Phosphatase 2A Regulatory Subunit Bβ2 Antagonizes Neuronal Survival by Promoting Mitochondrial Fission* , 2008, Journal of Biological Chemistry.
[65] R. Burgoyne,et al. Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling , 2007, Nature Reviews Neuroscience.
[66] T. Sørensen,et al. Influence of genes and family environment on adult smoking behavior assessed in an adoption study , 2001, Genetic epidemiology.
[67] K. Matsuo,et al. Significant association of interleukin 8 −251T/A polymorphism with smoking behavior in a Japanese population , 2005, Journal of Human Genetics.
[68] R. Nitsch,et al. Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A , 2002, The European journal of neuroscience.
[69] P. Goldman-Rakic,et al. Interaction with Neuronal Calcium Sensor NCS-1 Mediates Desensitization of the D2 Dopamine Receptor , 2002, The Journal of Neuroscience.
[70] R. Anney,et al. Association Between Dependent Smoking and a Polymorphism in the Tyrosine Hydroxylase Gene in a Prospective Population-Based Study of Adolescent Health , 2004, Behavior genetics.
[71] Christina N. Lessov-Schlaggar,et al. Genetics of nicotine dependence and pharmacotherapy. , 2008, Biochemical pharmacology.
[72] R. Ebstein,et al. Association of the serotonin transporter gene with smoking behavior. , 2005, The American journal of psychiatry.
[73] M. Munafo,et al. Lack of Association of 5-HTTLPR Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial , 2006, Cancer Epidemiology Biomarkers & Prevention.
[74] Melvin G McInnis,et al. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12 , 1999, Nature Genetics.
[75] S. David,et al. Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. , 2008, Drug and alcohol dependence.
[76] A. C. Collins,et al. Association of the neuronal nicotinic receptor β2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[77] M. Munafo,et al. Genes and cigarette smoking. , 2008, Addiction.
[78] P. Sullivan,et al. Association of the tryptophan hydroxylase gene with smoking initiation but not progression to nicotine dependence. , 2001, American journal of medical genetics.
[79] S. David,et al. Association of COMT Val108/158Met Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial , 2007, Cancer Epidemiology Biomarkers & Prevention.
[80] P. Muglia,et al. α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking , 2008, Molecular Psychiatry.
[81] K. Brady,et al. Genomewide Linkage Scan for Nicotine Dependence: Identification of a Chromosome 5 Risk Locus , 2007, Biological Psychiatry.
[82] K. Jackson. Tobacco Use, Access, and Exposure to Tobacco in Media Among Middle and High School Students – United States, 2004: , 2005 .
[83] R. Tyndale,et al. Overview of the pharmacogenomics of cigarette smoking , 2007, The Pharmacogenomics Journal.
[84] N. Martin,et al. Defining nicotine dependence for genetic research: evidence from Australian twins , 2004, Psychological Medicine.
[85] Ming D. Li,et al. Significant Association of ANKK1 and Detection of a Functional Polymorphism with Nicotine Dependence in an African-American Sample , 2009, Neuropsychopharmacology.
[86] T. Niu,et al. Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence , 2004, Journal of Human Genetics.
[87] M. Munafo,et al. Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial , 2004, BMJ : British Medical Journal.
[88] Marcus R Munafò,et al. Genetics and smoking cessation improving outcomes in smokers at risk. , 2007, American journal of preventive medicine.
[89] C. Na,et al. Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers , 2008, Psychiatric genetics.
[90] S. Wonnacott,et al. Presynaptic Nicotinic Modulation of Dopamine Release in the Three Ascending Pathways Studied by In Vivo Microdialysis: Comparison of Naive and Chronic Nicotine‐Treated Rats , 1997, Journal of neurochemistry.
[91] C. Husten,et al. Cigarette smoking among adults--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.
[92] J. Hewitt,et al. An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health. , 2006, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[93] R. Huganir,et al. Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897–NR1 , 2003, Journal of neurochemistry.
[94] K. Kendler,et al. The μ-opioid receptor gene and smoking initiation and nicotine dependence , 2006, Behavioral and Brain Functions.
[95] Ming D. Li,et al. A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European‐American smokers , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[96] S. David,et al. The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[97] T. Rebbeck,et al. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women , 2005, Pharmacogenetics and genomics.
[98] K. Kanyas,et al. Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[99] N. Martin,et al. Genetic and Social Determinants of Initiation and Age at Onset of Smoking in Australian Twins , 1999, Behavior genetics.
[100] G. Uhl,et al. Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs , 2007, BMC Genetics.
[101] R. Tyndale,et al. A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[102] R. Ebstein,et al. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes , 2006, Molecular Psychiatry.
[103] P. Khatri,et al. A systems biology approach for pathway level analysis. , 2007, Genome research.
[104] D. Hamer,et al. Depression vulnerability, cigarette smoking, and the serotonin transporter gene. , 2005, Addictive behaviors.
[105] Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999. , 2002, MMWR. Morbidity and mortality weekly report.
[106] M. Schmidt,et al. Interaction between the dopamine D4 receptor and the serotonin transporter promoter polymorphisms in alcohol and tobacco use among 15-year-olds , 2006, Neurogenetics.
[107] R. Lea,et al. Monoamine oxidase and tobacco dependence. , 2007, Neurotoxicology.
[108] C. Pomerleau,et al. Genome-wide linkage analysis for smoking-related regions, with replication in two ethnically diverse populations. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[109] CREB1 haplotypes and the relative reinforcing value of nicotine , 2007, Molecular Psychiatry.
[110] Ming D. Li,et al. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. , 2003, Addiction.
[111] E. Bowman,et al. EVIDENCE SUGGESTING THE ROLE OF SPECIFIC GENETIC FACTORS IN CIGARETTE SMOKING , 1998 .
[112] Scott F. Saccone,et al. Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study. , 2008, Addiction.
[113] C. Jepson,et al. Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence , 2006, The Pharmacogenomics Journal.
[114] S. David,et al. Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch , 2008, The Pharmacogenomics Journal.
[115] D. Conti,et al. Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation , 2008, Human molecular genetics.
[116] R. Tyndale,et al. Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence , 2005, Clinical pharmacology and therapeutics.
[117] J. Chatkin,et al. Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addiction , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[118] H. Checkoway,et al. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men , 2005, Neuroscience Letters.
[119] Jason D. Robinson,et al. The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms , 2007, The Pharmacogenomics Journal.
[120] Nicholas G Martin,et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. , 2007, Human molecular genetics.
[121] G. Willemsen,et al. Linkage analysis of smoking initiation and quantity in Dutch sibling pairs , 2004, The Pharmacogenomics Journal.
[122] Ming D. Li,et al. Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. , 2005, American journal of human genetics.
[123] M. Lynskey,et al. The genetics of tobacco use: methods, findings and policy implications , 2002, Tobacco control.
[124] Ming D. Li,et al. Significant association of BDNF haplotypes in European‐American male smokers but not in European‐American female or African‐American smokers , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[125] D. Comings,et al. The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. , 1996, Pharmacogenetics.
[126] R. Tyndale,et al. The Role of CYP2A6 in the Emergence of Nicotine Dependence in Adolescents , 2007, Pediatrics.
[127] Douglas A. Hosack,et al. Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.
[128] Vincenzo De Luca,et al. Evidence of Association between Smoking and α7 Nicotinic Receptor Subunit Gene in Schizophrenia Patients , 2004, Neuropsychopharmacology.
[129] A. C. Collins,et al. The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. , 2007, Human molecular genetics.
[130] C. Lerman,et al. Elucidating the role of genetic factors in smoking behavior and nicotine dependence , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[131] Ming D. Li,et al. Detection of genetic association and a functional polymorphism of dynamin 1 gene (DNM1) with nicotine dependence in European and African Americans , 2008, Neuropsychopharmacology.
[132] M. Spitz,et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. , 1998, Journal of the National Cancer Institute.
[133] Ming D. Li,et al. Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. , 2005, Human molecular genetics.
[134] K. Bucholz,et al. Common genetic vulnerability for nicotine and alcohol dependence in men. , 1999, Archives of general psychiatry.
[135] Ming D. Li,et al. Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. , 2008, Human molecular genetics.
[136] Ming D. Li,et al. Significant association of DRD1 with nicotine dependence , 2008, Human Genetics.
[137] J. Hennig,et al. GENETIC STUDY: Association between the BclI glucocorticoid receptor polymorphism and smoking in a sample of patients with obstructive airway disease , 2007, Addiction biology.
[138] Martin H. Schmidt,et al. Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.
[139] L. Garofano,et al. Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[140] C. Lerman,et al. Interacting effects of genetic predisposition and depression on adolescent smoking progression. , 2004, The American journal of psychiatry.
[141] Ming D. Li,et al. Bitter taste receptor gene polymorphisms are an important factor in the development of nicotine dependence in African Americans , 2008, Journal of Medical Genetics.
[142] Anna M. Lee,et al. CYP2B6 Genotype Alters Abstinence Rates in a Bupropion Smoking Cessation Trial , 2007, Biological Psychiatry.
[143] Vernell S. Williamson,et al. Cannabinoid receptor 1 gene association with nicotine dependence. , 2008, Archives of general psychiatry.
[144] P. Shields,et al. Tryptophan hydroxylase gene variant and smoking behavior. , 2001, American journal of medical genetics.
[145] Tianhua Niu,et al. A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. , 2004, American journal of human genetics.
[146] C. Jepson,et al. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[147] K. Ikeda,et al. Cholecystokinin (CCK) and the CCKA receptor gene polymorphism, and smoking behavior , 2005, Psychiatry Research.
[148] Ming D. Li,et al. Association of Specific Haplotypes of Neurotrophic Tyrosine Kinase Receptor 2 Gene (NTRK2) with Vulnerability to Nicotine Dependence in African-Americans and European-Americans , 2007, Biological Psychiatry.
[149] E. Nestler. Is there a common molecular pathway for addiction? , 2005, Nature Neuroscience.
[150] A. Ishizaka,et al. Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms , 2006, European Respiratory Journal.
[151] E. Nestler,et al. The many faces of CREB , 2005, Trends in Neurosciences.
[152] T. Payne,et al. β-Arrestins 1 and 2 are associated with nicotine dependence in European American smokers , 2008, Molecular Psychiatry.
[153] T J Payne,et al. Linkage and association studies in African- and Caucasian-American populations demonstrate that SHC3 is a novel susceptibility locus for nicotine dependence , 2007, Molecular Psychiatry.
[154] Hans-Peter Lenhof,et al. GeneTrailExpress: a web-based pipeline for the statistical evaluation of microarray experiments , 2008, BMC Bioinformatics.
[155] K. Kendler,et al. Association of the phosphatase and tensin homolog gene (PTEN) with smoking initiation and nicotine dependence , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[156] E. Bowman,et al. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[157] P. Sullivan,et al. The genetic epidemiology of smoking. , 1999, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[158] M. Hutz,et al. Tobacco smoking and the ADRA2A C-1291G polymorphism , 2007, Journal of Neural Transmission.
[159] D. Collier,et al. Association of the serotonin transporter gene, neuroticism and smoking behaviours , 2008, Journal of Human Genetics.
[160] L. Kozlowski,et al. GENETIC STUDY: Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene–gene interactions associated with smoking‐related behaviors , 2007, Addiction biology.
[161] P. Shields,et al. The role of the serotonin transporter gene in cigarette smoking. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[162] S. Wonnacott,et al. Presynaptic nicotinic ACh receptors , 1997, Trends in Neurosciences.
[163] J. Stapleton,et al. GENETIC STUDY: Association between dopamine transporter genotypes and smoking cessation: a meta‐analysis , 2007, Addiction biology.
[164] G. Breen,et al. Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment , 2007, Pharmacogenetics and genomics.
[165] M. Tsuang,et al. The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[166] B R Flay,et al. Stages in the development of adolescent smoking. , 2000, Drug and alcohol dependence.
[167] P. Sullivan,et al. A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence , 2004, Psychological Medicine.
[168] G. Siest,et al. Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort , 2005, The Pharmacogenomics Journal.
[169] Su-Jin Lee,et al. The association between the DRD2 TaqI A polymorphism and smoking cessation in response to acupuncture in Koreans. , 2005, Journal of alternative and complementary medicine.
[170] D. Mant,et al. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. , 2000, Pharmacogenetics.
[171] Richard A. Brown,et al. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. , 2007, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.